Experience the synergy of advanced peptide therapies that address aging at both the structural and cellular levels
This approval is based on the results of JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS), multicenter, placebo-controlled, double-blind, randomized Phase III clinical trial in 130 patients with ALS, that was conducted as an investigator-initiated trial by a research team with Extraordinary Professor Ryuji Kaji (Principal Investigator), Tokushima University, and Professor Yuishin Izumi (Coordinating Investigator), the Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, and Professor Satoshi Kuwabara (Coordinating Investigator), the Department of Neurology, Chiba University Graduate School of Medicine
Whereas the endocrine system is the main secretory pathway, GH is also expressed in many extrapituitary tissues in which it has autocrine and paracrine effects
Recent innovations also exploit the intrinsic interactions of zinc-based nanomaterials with intracellular organelles to enhance therapeutic delivery and monitoring
McCord JM (1993) Human disease, free radicals, and the oxidant/antioxidant balance
Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors
